Exercise or conversion by Perceptive Advisors Llc of 36300 shares of LianBio ADR subject to Rule 16b-3
About 67% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LianBio |
Filed transaction by Lianbio director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
LianBio ADR Fundamental Analysis
We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
LianBio ADR is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
LianBio ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.
Peers
LianBio ADR Related Equities
LRMR | Larimar Therapeutics | 5.28 | ||||
ABOS | Acumen Pharmaceuticals | 5.22 | ||||
DAWN | Day One | 4.24 | ||||
TERN | Terns Pharmaceuticals | 3.54 | ||||
INZY | Inozyme Pharma | 2.75 | ||||
SNSE | Sensei Biotherapeutics | 2.33 | ||||
NXTC | NextCure | 1.37 | ||||
FENC | Fennec Pharmaceuticals | 0.59 | ||||
ACHL | Achilles Therapeutics | 0.72 | ||||
ASMB | Assembly Biosciences | 2.29 | ||||
VRCA | Verrica Pharmaceuticals | 3.13 | ||||
ELDN | Eledon Pharmaceuticals | 3.37 | ||||
TIL | Instil Bio | 4.27 | ||||
NUVB | Nuvation Bio | 7.61 | ||||
HOOK | Hookipa Pharma | 7.84 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stocks Directory Find actively traded stocks across global markets |